- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccine third dose and cancer patients: necessity or luxury?
Authors
Keywords
-
Journal
ESMO Open
Volume 6, Issue 6, Pages 100306
Publisher
Elsevier BV
Online
2021-11-11
DOI
10.1016/j.esmoop.2021.100306
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rich countries should tithe their vaccines
- (2021) Gavin Yamey NATURE
- Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors
- (2021) J. Barrière et al. ANNALS OF ONCOLOGY
- 1557O Adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients: The CAPTURE study
- (2021) S.T.C. Shepherd et al. ANNALS OF ONCOLOGY
- Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
- (2021) Alfredo Addeo et al. CANCER CELL
- Seroconversion rates following COVID-19 vaccination among patients with cancer
- (2021) Astha Thakkar et al. CANCER CELL
- Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer
- (2021) Sidse Ehmsen et al. CANCER CELL
- Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
- (2021) Mario Mairhofer et al. CANCER CELL
- The devil in the details: Herd immunity and pandemic response
- (2021) Beau Schaeffer et al. Cell Host & Microbe
- Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
- (2021) Victoria G. Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine nationalism and the dynamics and control of SARS-CoV-2
- (2021) Caroline E. Wagner et al. SCIENCE
- How the world is (not) handling surplus doses and expiring vaccines
- (2021) Jane Feinmann BMJ-British Medical Journal
- Profiteering from vaccine inequity: a crime against humanity?
- (2021) Fatima Hassan et al. BMJ-British Medical Journal
- Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021
- (2021) Ashley Fowlkes et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021
- (2021) Mark W. Tenforde et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021
- (2021) Catherine M. Brown et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
- (2021) Amir Massarweh et al. JAMA Oncology
- Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
- (2021) Tal Goshen-Lago et al. JAMA Oncology
- Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group
- (2021) Helena Linardou et al. Cancers
- High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers
- (2021) R. Palich et al. ANNALS OF ONCOLOGY
- SARS-CoV-2 mutational cascades and the risk of hyper-exponential growth
- (2021) John M. Halley et al. MICROBIAL PATHOGENESIS
- Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
- (2021) Rachna T. Shroff et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search